Search trials for
Showing NN of NN trials
Enrolling

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric U...

The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus lansoprazole in the treatment of participants...

Enrolling

Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointesti...

This is a multi-center, open label, repeat dose, Phase 1 study consisting of a Dose Escalation Phase and a Dose...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid...

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid...

Enrolling

A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With...

This is a 2-arm, randomized, open-label, international, multicenter study comparing the efficacy of DCC-2618 to sunitinib in GIST patients who...

Enrolling

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced...

The purpose of this study is to evaluate the effects, good and/or bad, of MEK162 and imatinib on the patient...

Enrolling

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Sele...

This study is a Phase Ib, multi-center, open-label study of TNO155 in combination with spartalizumab or ribociclib with a dose...

Enrolling

Evaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With...

The primary objective is to compare the incidence of gastrointestinal AEs in patients treated with IPF, initiating pirfenidone for the...

Not Yet Enrolling

Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With...

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal or Colorectal Cancer

Not Yet Enrolling

Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neop...

Prospective, multicenter, single-arm, non-controlled, 60 subjects enrolled and 14 days follow up for evaluate the safety and utility of VelaTM...